Report overview
This report contains market size and forecasts of Chronic Pain Management Drugs in Global, including the following market information:
Global Chronic Pain Management Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Chronic Pain Management Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Opioids Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chronic Pain Management Drugs include Pfizer Inc., Depomed Inc., Endo International plc., Purdue Pharma L.P., Novartis AG, AstraZeneca plc., Johnson and Johnson Services Inc., Merck & Co. and Abbott Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Pain Management Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Pain Management Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Chronic Pain Management Drugs Market Segment Percentages, by Type, 2022 (%)
Opioids
Non-narcotic Analgesic
Others
Global Chronic Pain Management Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Chronic Pain Management Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Chronic Pain Management Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Chronic Pain Management Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Pain Management Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chronic Pain Management Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Depomed Inc.
Endo International plc.
Purdue Pharma L.P.
Novartis AG
AstraZeneca plc.
Johnson and Johnson Services Inc.
Merck & Co.
Abbott Laboratories
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
